Digital health startup Akili cuts staff by 40%, abandons prescription model


Akili will no longer pursue prescriptions for its digital therapeutics, instead switching entirely to over-the-counter, direct-to-consumer sales.

Previous Greater MSP vying for $75M to make MN an AI-enabled global medtech hub
Next Uli Chi named a PSBJ Director of the Year